Pan-specific vaccine to control Streptococcus agalactiae disease in tilapia aquaculture

点击翻译按钮获取中文摘要

As the world population grows and becomes more affluent, an increasing number of people includeprotein in their diet. Aquaculture is the fastest growing source of animal protein and a major source ofincome in Asia, South-America and Africa. Tilapia is a popular fish, both with farmers and consumers,but disease can cause massive losses on tilapia farms. Streptococcus agalactiae, which can affect tilapiaas well as people, is a major cause of such losses. Currently, antibiotics are commonly used to combatthis problem. This is not sustainable because of the risk of antimicrobial resistance. As an alternative, wepropose to develop a vaccine that would protect fish from all types of S. agalactiae that affect them. Thisproject brings together scientific expertise in the area of fish disease and vaccine development andcommercial expertise in vaccine production and distribution. Jointly, the partners aim to provide theglobal aquaculture industry with effective and affordable tools for sustainable disease control.